Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001123292-26-000187

Options or other derivatives

  • 10% owner bought 3,739,000 shares at $0.53 ($1,999,991)

From the SEC's structured data for this filing

Trades in this filing

GILEAD SCIENCES, INC. · 10% owner

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-13 Purchase : show line 1 in the form Prefunded Warrants (right to buy) +3,739,000 $0.53 $1,999,991 40,384,266 D
Loading xslF345X05/form4.xml…